Indivior Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| INDV | COLL | PCRX | ALKS | AQST | SUPN | |
|---|---|---|---|---|---|---|
| Market cap | 4.26B | 717.85M | 1.45B | 6.75B | 603.71M | 2.49B |
| P/E (TTM) | 12.9 | 17.4 | 103.9 | 105.9 | — | — |
| Forward P/E | 7.4 | 3.3 | 10.5 | 22.3 | -8.4 | 9.6 |
| Price/book | -20.5 | 2.3 | 2.2 | 3.7 | -10.7 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +50.10% | −31.05% | +63.12% | +25.15% | −30.09% | −11.80% |
| Today | +0.64% | −0.18% | +0.11% | −0.86% | +0.63% | +0.33% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All INDV news ›MILLENNIUM MANAGEMENT LLC Adds Indivior Pharmaceuticals Inc (IND
GuruFocus MILLENNIUM MANAGEMENT LLC Adds Indivior Pharmaceuticals Inc (INDV) Shares -- Stock Looks 45% Overvalued on GF Value A Measured Addition to a Broad Portfolio On Sept. 23, 2026, MILLENNIUM MANAGEMENT LLC (Trades, Portfolio)…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
gurufocus.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.